NASDAQ:LNSR LENSAR (LNSR) Stock Price, News & Analysis $4.50 -0.14 (-3.10%) Closing price 11/20/2026 03:58 PM EasternExtended Trading$4.47 -0.03 (-0.67%) As of 11/20/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About LENSAR Stock (NASDAQ:LNSR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LENSAR alerts:Sign Up Key Stats Today's Range$4.41▼$4.6850-Day Range$4.50▼$7.8152-Week Range$4.30▼$12.94Volume55,031 shsAverage Volume69,610 shsMarket Capitalization$55.27 millionP/E RatioN/ADividend YieldN/APrice Target$11.00Consensus RatingHold Company Overview LENSAR, Inc. develops and markets laser-based technology for ophthalmic surgery, with a focus on procedures used to treat cataracts. Its systems are designed to assist surgeons with key steps in cataract surgery, including the creation of incisions and the fragmentation of the eye’s natural lens. The company’s products include the ALLY Adaptive Cataract Treatment System and the LENSAR Laser System, which use imaging and software to support surgical planning and treatment. LENSAR also offers related software, accessories and services for ophthalmic practices and surgical facilities. Based in Orlando, Florida, LENSAR serves eye surgeons and healthcare providers in the United States and international markets. The company was founded in 2004 and focuses on developing technology intended to support precision and workflow in cataract surgery.AI Generated. May Contain Errors. Read More LENSAR Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreLNSR MarketRank™: 2.00952914798 of 5 starsLENSAR scored higher than 40% of companies evaluated by MarketBeat, and ranked 620th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingLENSAR has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialLENSAR has a consensus price target of $11.00, representing about 144.7% upside from its current price of $4.50.Amount of Analyst CoverageLENSAR has only been the subject of 2 research reports in the past 90 days.Read more about LENSAR's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of LENSAR is -11.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LENSAR is -11.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLENSAR has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.29% of the float of LENSAR has been sold short.Short Interest Ratio / Days to CoverLENSAR has a short interest ratio ("days to cover") of 6.77.Change versus previous monthShort interest in LENSAR has recently decreased by 0.25%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLENSAR does not currently pay a dividend.Dividend GrowthLENSAR does not have a long track record of dividend growth. News and Social Media1.9 / 5News Sentiment0.11 News SentimentLENSAR has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for LENSAR this week, compared to 1 article on an average week. Company Ownership1.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LENSAR insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $169,989.00 in company stock.Percentage Held by Insiders65.80% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.15% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LENSAR's insider trading history. Receive LNSR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LNSR Stock News HeadlinesLENSAR (NASDAQ:LNSR) Director Elizabeth O'farrell Sells 22,214 Shares of StockNovember 20 at 7:22 AM | insidertrades.comSanara MedTech (NASDAQ:SMTI) vs. LENSAR (NASDAQ:LNSR) Financial SurveyNovember 20 at 4:00 AM | americanbankingnews.comCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.November 22 at 1:00 AM | Decentralized Masters (Ad)Analyzing LENSAR (NASDAQ:LNSR) & Precision Optics (NASDAQ:POCI)November 19 at 2:14 AM | americanbankingnews.comLENSAR (NASDAQ:LNSR) Rating Lowered to Sell at Wall Street ZenNovember 14, 2026 | americanbankingnews.comContrasting LENSAR (LNSR) and The CompetitionNovember 13, 2026 | americanbankingnews.comLENSAR, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 12, 2026 | marketscreener.comMBTIG Research Issues Pessimistic Forecast for LENSAR (NASDAQ:LNSR) Stock PriceNovember 12, 2026 | americanbankingnews.comSee More Headlines LNSR Stock Analysis - Frequently Asked Questions How have LNSR shares performed this year? LENSAR's stock was trading at $11.63 at the beginning of the year. Since then, LNSR stock has decreased by 61.3% and is now trading at $4.4960. How were LENSAR's earnings last quarter? LENSAR, Inc. (NASDAQ:LNSR) announced its earnings results on Tuesday, November, 10th. The company reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.29. The company earned $14.13 million during the quarter, compared to analyst estimates of $14.30 million. LENSAR had a net margin of 56.07% and a trailing twelve-month return on equity of 1,254.25%. Read the conference call transcript. Who are LENSAR's major shareholders? LENSAR's top institutional investors include Marshall Wace LLP (1.50%), Mink Brook Asset Management LLC (0.81%), State Street Corp (0.59%) and Goldman Sachs Group Inc. (0.40%). View institutional ownership trends. How do I buy shares of LENSAR? Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/10/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 2 days ago, LNSR's financial health entered the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:LNSR CIK1320350 Webwww.lensar.com Phone888-536-7271FaxN/AEmployees150Year FoundedN/APrice Target and Rating Average Price Target for LENSAR$11.00 High Price Target$13.00 Low Price Target$9.00 Potential Upside/Downside+144.7%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$34.28 million Net Margins56.07% Pretax Margin56.07% Return on Equity1,254.25% Return on Assets49.13% Debt Debt-to-Equity RatioN/A Current Ratio2.25 Quick Ratio0.98 Sales & Book Value Annual Sales$60.08 million Price / Sales0.92 Cash FlowN/A Price / Cash FlowN/A Book Value$0.90 per share Price / Book5.00Miscellaneous Outstanding Shares12,294,000Free Float4,205,000Market Cap$55.27 million OptionableOptionable Beta1.03 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:LNSR) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredRetirement balance looks fine, so why do you feel behind?Does your retirement balance look fine while you still feel like you're falling behind? On Wednesday, December...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.